WeVote

Bill

Bill

AB 725

Source plasma donation.

2025-2026 Regular Session Introduced by Juan Carrillo and 4 co-sponsors

AB 725 modifies California's source plasma donation regulations, affecting facility standards, donor compensation, and safety protocols for plasma collection and therapeutic use.

In committee: Held under submission.
0
WeVote Research Nonpartisan
Bill Summary · AB 725

Legislative bill overview

AB 725 addresses regulations and standards for source plasma donation in California. The bill appears to establish or modify requirements for plasma collection facilities, donor compensation, and safety protocols. Specific legislative language would clarify whether this expands access, increases safety standards, or adjusts compensation structures for plasma donors.

Why is this important

Source plasma donation is a critical component of the blood supply system, providing materials for immunoglobulins and other life-saving therapeutics. California's plasma donation market significantly impacts national supply chains, making state-level regulations influential. Changes to compensation, facility standards, or donor eligibility could affect both the availability of plasma products and donor participation rates.

Potential points of contention

  • Donor compensation levels: Plasma donation currently pays donors, unlike whole blood donation; any changes to payment structures could spark debate between industry, donor advocacy groups, and those concerned about exploiting economically vulnerable populations
  • Safety and health standards: Stricter facility requirements or health screening protocols may increase operational costs for collection centers, potentially reducing their number or accessibility
  • Eligibility criteria: Any modifications to who can donate (age, health status, frequency) could either expand or restrict the donor pool, affecting supply and equity considerations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.